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Abstract
Background: Schwannomas located in the periportal region are extremely rare. Only 14 cases have been reported
in the medical literature worldwide. Cases of porta hepatic schwannomas reported in the literature worldwide were
reviewed. As a result, it is very challenging for surgeons to make a preoperative diagnosis due to its rarity and
nonspecific imaging manifestations.
Case Presentation: A 57-year-old Chinese female was admitted to our institution with complaint of upper
abdominal distension and the abdominal CT in the local hospital revealed a hypodense mass in the porta hepatis.
A fine needle aspiration (FNA) was made to confirm the diagnosis, but the result was just suggestive of spindle cell
neoplasia. Eventually, the patient underwent surgery and postoperative pathology confirmed schwannoma in porta
hepatis. The patient recovered uneventfully with no evidence of recurrence after a follow-up period of 41 months.
Conclusions: It is essential for the final diagnosis of porta hepatic schwannomas to combine histological
examination with immunohistochemistry after surgery. The main treatment of porta hepatic schwannomas is
complete excision with free margins and no lymph node dissection. In some cases, biliary reconstruction or the
proper hepatic and the gastroduodenal artery resection was performed because the tumor was inseparably
attached to the extrahepatic bile duct or the proper hepatic and the gastroduodenal artery. Malignant
transformation of schwannomas is very rare and the overall prognosis is satisfactory.
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Background
The periportal region is a complex anatomic region be-
tween the superior aspect of the first portion of the duo-
denum and the porta hepatis, including the
hepatoduodenal ligament and the extrahepatic bile duct,
portal vein, hepatic artery, autonomic nerve fibers, and
lymph nodes [1]. When patients exhibit symptoms of
abdominal pain or jaundice or show no symptoms, and
a mass in the periportal region is detected in image
scans, the diagnosis of a cholangiocarcinoma or a gastro-
intestinal stromal tumor (GIST) may be considered first.
However, in rare cases, the diagnosis is of a porta hep-
atic schwannoma. Porta hepatic schwannomas are ex-
tremely rare, with only 14 cases reported in the
literature to date. Of the 14 cases, the mean age of the
patients was 45 years (range 29–74 years), and the male-
female ratio was 6:8. The literature depicted tumors
varying from 2.2 cm (the average tumor diameter line)
to 7.5 cm in size, with a median of approximately
4.8 cm. For the mass in porta hepatic, it is difficult to
perform a biopsy because of vessel interposition. So, the
surgeons are inclined to make a fine needle aspiration
(FNA) because of lower risk of bleeding. In the 14 cases,
the FNA was operated only for two patients, and none
underwent biopsy before surgery. But, the FNA usually
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fails to provide the immunohistochemistry, which is im-
perative to make a diagnosis for the mesenchymal tu-
mors. In most cases, the final diagnosis of schwannoma
was confirmed by postoperative pathological examination.
Herein, we report a case of schwannoma located in
the porta hepatis and review cases reported in the litera-
ture worldwide for a better understanding of the clinical
and pathological features of porta hepatic schwannomas.
Case presentation
On October 12, 2011, a 57-year-old Chinese female was
admitted to our institution with complaint of upper
abdominal distension for 2 weeks. She denied any ab-
dominal trauma or surgeries in her life. No specific find-
ings were noted in her family history and personal
history. And, she was taking no medications. Before this
treatment, she went to the local hospital where an ab-
dominal ultrasound was performed revealing a mass in
the head of the pancreas. No abnormalities were de-
tected upon clinical examination and in laboratory in-
vestigations. The computer tomography (CT) scan
(Fig. 1a–c) revealed a 4.0 × 3.2 × 3.0-cm hypodense mass
in the porta hepatis, mildly enhanced in arterial phase,
and moderately enhanced in portal phase. There was no
Fig. 1 Abdominal CT and MRI findings of the patient. a Plain CT scan revealed a 4.0 × 3.2 × 3.0-cm hypodense mass in the porta hepatis (black arrow).
b Enhanced CT scan revealed a mildly enhanced mass in arterial phase (black arrow). c Moderately enhanced mass in portal phase (black arrow). d MRI
revealed a 4.0 × 3.0-cm mass in the sagittal section (black arrow). e Low signal intensity in T1-weighted imaging (black arrow). f High signal intensity in
T2-weighted imaging (black arrow)
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clear boundary between the mass and the caudate lobe
of the liver, and the lower edge of the lesion was close to
the neck of pancreas, pressing down on the common
hepatic artery. No enlarged hilar lymph nodes or ex-
ogenous caudate lobe tumor were identified. The mag-
netic resonance imaging (MRI) (Fig. 1d–f ) showed the
long T1 and T2 signal mass in the porta hepatis, with
4.0 × 3.0 cm. The imaging feature on MRI was similar to
CT. Fine needle aspiration guided by endoscopic ultra-
sonography revealed spindle cells arranged in bundles
and palisades, with no nuclear atypia, suggestive of a
spindle cell neoplasia. With a high suspicion of a GIST,
diagnostic laparoscopy was performed. The tumor was
located in the porta hepatis, tightly pressing the hepato-
duodenal ligament, and the caudate lobe and the pan-
creas were not involved. Then, after careful dissection,
the tumor was found to be in close contact with the
common hepatic artery and cystic artery. Subsequently,
the patient underwent laparotomy, and intraoperative
frozen-section examination revealed a mesenchymal tumor
in the porta hepatis, highly suspicious of a GIST. So, the
tumor was macroscopically resected en-bloc with the in-
vaded common hepatic artery, and the blood supply of the
proper hepatic artery was good through the gastroduodenal
artery. And, cholecystectomy was also performed. Post-
operative detailed histopathological examination showed
benign schwannoma (Fig. 2a–d): CD117(−), S-100(+),
GFAP(+), CD34(−), SMA(−), and Ki-67(+, little). Postopera-
tively, the patient recovered uneventfully. No symptoms or
signs of recurrence have been observed in our patient dur-
ing the 41 months of follow-up.
Literature review
PubMed, Google scholar (http://scholar.google.com.cn/),
the National Knowledge Infrastructure (http://www.cnki.-
net//), the Chinese periodical Database of Science and
Technology (http://lib.cqvip.com/), and the Wanfang Data
Knowledge Service Platform (http://www.wanfangdata.-
com.cn/) were searched for cases of porta hepatic schwan-
noma between 1985 and 2015, adding up to 14 patients.
Details of all the 14 cases and the current case shown in
Tables 1 and 2 summarized the important available clini-
copathological factors. Continuous data are presented as
mean ± standard deviation and range.
Discussion
Schwannoma, also known as neurilemmoma, is a tumor
derived from Schwann cells, which form the inner portion
of the peripheral nerve sheath [2]. The exact etiology and
pathogenesis of schwannomas remain unclear, but recent
research has indicated that defects in merlin gene are re-
sponsible for both sporadic and genetically acquired
schwannomas, and the mechanisms by which merlin loss
triggers tumor development are being unraveled [3].
Fig. 2 a Histological examination findings of the tumor: bundles of uniform spindle cells whose elongated nuclei were arranged in a palisading
pattern (hematoxylin and eosin; magnification, ×100). b Immunohistochemistry revealed that tumor cells were positive for S-100 protein (magnification,
×100). c Immunohistochemistry revealed that tumor cells were negative for CD117 (magnification, ×100). d Immunohistochemistry revealed that
tumor cells were positive for GFAP (magnification, ×100)
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Theoretically, the tumor can affect any nerve trunk or any
organ, except the olfactory and optic nerves, which lack
Schwann cells [4]. The most common locations for
schwannomas are the upper extremities, trunk, head, and
neck, retroperitoneum, mediastinum, pelvis, and periton-
eum [5]. Intraperitoneal schwannomas are relatively rare
and mostly located in solid organs such as the liver and
the pancreas. However, porta hepatic schwannomas are
extremely rare, with only 14 cases reported in the litera-
ture to date. The sympathetic and parasympathetic fibers
are distributed along the hepatic and gastroduodenal ar-
teries, with their branches interwoven into a network,
which is the anatomical location of occurrence of the
porta hepatic schwannoma [6].
Schwannomas most commonly occur in patients be-
tween the ages of 20 and 50 years with equal fre-
quency in men and women [7]. For cases of porta
hepatic schwannoma, the mean age of the patients
was 48 years (range 29–74 years), and the male-
female ratio was 6:9. Symptoms caused by schwanno-
mas vary with the site and size of the tumors. In the
15 cases, the lesion was located in the porta hepatis
in nine patients (60 %), hepatoduodenal ligament in
five patients (33 %), and proper hepatic artery in one
patient (7 %). The literature depicts tumors varying
from 2.2 cm (the average tumor diameter line) to
7.5 cm in size, with a median of approximately
4.7 cm. Patients with porta hepatic schwannomas may
exhibit symptoms by compressing adjacent structures
such as the bile duct and the gastrointestinal tract. In
the literature, 40 % of the patients were asymptomatic
and 60 % of the patients were symptomatic. The most
common symptom was abdominal distension/abdom-
inal discomfort (5/15 patients or 33 %), followed by
abdominal pain (4/15 patients or 27 %), jaundice/dark
urine/colorless stool/pruritus (2/15 patients or 13 %),
nausea/vomiting/anorexia (1/15 patients or 7 %), and
weight loss (1/15 patients or 7 %).
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Patients with porta hepatic schwannomas usually
present with a porta hepatis or hepatoduodenal ligament
mass on imaging studies, and it is very challenging for
surgeons to make a preoperative diagnosis due to its rar-
ity and nonspecific clinical and imaging characteristics.
The ultrasound imaging often shows isoechoic or hypoe-
choic solid masses with well-defined limits. Generally, a
CT scan shows a well-defined hypodense heterogenous
mass with peripheral enhancement [8]. Schwannomas
on the MRI are usually masses with hypointensity on
T1-weighted images and heterogenous hyperintensity or,
sometimes internal heterogeneous mixed hypo and
hyperintensity on T2-weighted images [9]. Author Co-
hen has presented histologic evidence suggesting that
the hypo-density areas and inhomogeneities in schwan-
nomas are due to hypocellular areas adjacent to more
cellular regions and/or hypocellular areas adjacent to
dense bundles of collagen, xanthomatous formation, and
cystic degeneration within the tumors [10]. In the
present case, the CT and MRI showed a homogeneous
mass with peripheral enhancement in the porta hepatis.
When a solitary, well-demarcated mass occurs in the
porta hepatis, differential diagnosis should be made in-
cluding the following diseases: lymphoma, giant lymph
node hyperplasia (GLNH), lymph node tuberculosis, and
lesser sac benign smooth muscle tumors such as leio-
myomas, nerve sheath tumors, and hemangiomas origin-
ating in the lesser sac as well as stromal tumors of the
gastrointestinal tract protruding into the lesser sac [11].
Considering that imaging manifestations of porta hepatic
schwannomas are nonspecific, patients are usually
misdiagnosed preoperatively, unless by biopsy. In the 15
cases, the FNA was operated only for three patients, in-
cluding the present case. However, the result of FNA
may be inconsistent with final pathologic results [12].
Therefore, postoperative pathologic examination is still
the gold standard in the diagnosis of schwannoma.
Overall, it is essential for the diagnosis of schwannoma
to combine histological examination with immunohisto-
chemistry. Macroscopically, small schwannomas tend to
be spheroidal, whereas larger tumors can be sausage-
shaped, ovoid, or irregularly lobulated [13]. Larger
schwannomas have a tendency to undergo secondary de-
generation such as pseudocystic regression, calcification,
and hemorrhage [14], which can explain inhomogenei-
ties in a portion of schwannomas. In the 15 cases, seven
cases (47 %) underwent cystic changes or calcification.
Microscopically, the hallmark of schwannoma is the pat-
tern of alternating Antoni A and B areas, with varying
relative amounts [15]. The Antoni A area is hypercellu-
lar and characterized by closely packed spindle cells with
occasional nuclear palisading and Verocay bodies,
whereas the Antoni B area is hypocellular and is occu-
pied by loosely arranged tumor cells [16]. Two kinds of
structures often coexist in the same tumor, but most
with one main type. There were two cases of cellular
schwannoma in 15 cases characterized by predominantly
Antoni A areas histologically [17, 18].
Immunohistochemical staining is strongly and dif-
fusely positive for S-100 protein in a schwannoma con-
sistent with the finding of a nerve sheath tumor [10]. A
few gastrointestinal stromal tumors are positive for S-
Table 2 Summary of clinicopathological data from 15 cases of porta hepatic schwannoma
n (%) or mean ± SD (range)
Age (years) 48.3 ± 13.7 (29–74)
Sex (male/female), (male %) 6/9 (40 %)
Symptoms
Asymptomatic 6 (40 %)
Symptomatic
Abdominal distension/abdominal discomfort 5 (33 %)
Abdominal pain 4 (27 %)
Jaundice/dark urine/colorless stool/pruritus 2 (13 %)
Weight loss 1 (7 %)
Nausea/vomiting/anorexia 1 (7 %)
Location
Porta hepatis 9 (60 %)
Hepatoduodenal ligament 5 (33 %)
Proper hepatic artery 1 (7 %)
Mean size (cm), (n = 15) 4.7 ± 1.6 (2.2–7.5)
Mean follow-up months (n = 6) 16.0 ± 14.5 (3–41)
Disease related mortality 0 (0 %)
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100; however, they are also positive for either CD34 or
CD117 [19]. As a contrast, a schwannoma is negative for
both CD34 and CD117 [20]. A leiomyoma would be
negative for S-100 and positive for desmin or smooth
muscle actin [19]. In addition, we also demand to make
a differential diagnosis with malignant peripheral nerve
sheath tumor (MPNST), although malignant transform-
ation of these tumors is very rare [21]. MPNSTs are usu-
ally characterized by high cell density, obvious cell
atypia, more pathological mitotic, diverse cellular com-
ponents, and it is common to see tumor necrosis,
CK(+), EMA(+), and CEA(+) [18].
The main treatment of porta hepatic schwannomas is
complete excision with free margins and no lymph node
dissection. In the 15 cases, seven patients underwent
complete tumor excision. But, two patients underwent
tumor excision en bloc with hepatic artery resection be-
cause of the intraoperative finding of tumor invasion of
the hepatic artery (including the present case) [22]. In
addition, one patient underwent tumor or bile duct exci-
sion and Roux-en-Y hepaticojejunostomy because the
tumor was attached to the extrahepatic bile duct [4].
One patient underwent tumor excision en bloc with T-
tube drainage because a small rupture of the bile duct
wall caused bile leakage during the dissection of the ex-
trahepatic bile duct [17]. One patient underwent tumor
excision en bloc with right hepatectomy because the
right anterior portal vein was invaded [12], and the de-
tails of surgical resection were not specified in three pa-
tients. Postoperative pathological results indicated 13
cases of benign schwannoma and two cases of cellular
schwannoma which is considered as a subtype of
schwannoma [17, 18]. The complete excision of the
tumor is curative and most cases do not relapse and
additional treatments are not necessary. The overall
prognosis is very good [23]. In the follow-up of 6/15 pa-
tients, there was no recurrence with a mean follow-up of
16 months (range 3–41 months).
Conclusions
Porta hepatic schwannomas are extremely rare. It is a
big challenge to make a correct diagnosis preoperatively
due to its rarity and nonspecific imaging and clinical
manifestations. Postoperative pathologic examination is
still the gold standard in the diagnosis of schwannoma.
The main treatment of benign schwannomas is complete
excision with free margins and no lymph node dissection
and biliary surgery when needed. Malignant transform-
ation of schwannomas is very rare and the overall prog-
nosis is satisfactory after surgery.
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